Faeth’s PIKTOR plus paclitaxel combo gains FDA fast track status
The designation applies to those who have previously undergone platinum-based chemotherapy and an immune checkpoint inhibitor.
Drug Development
Fulcrum and Slate Medicines sign merger agreement
EMA validates Pfizer and Valneva’s Lyme disease vaccine
FDA grants fast track status to Phanes’ spevatamig for advanced BTC
BMS secures FDA accelerated approval for Zenbexus in multiple myeloma
Xanadu and University of Alberta to develop quantum algorithms for cancer
Akeso secures China NMPA authorisation for ivonescimab combo
Remepy secures $36m funding for hybrid drug pipeline expansion
